Table 2.
Demographic and clinical characteristics
| Characteristics | No chemotherapy (n = 24) | Chemotherapy (n = 48) | Test of association p values |
|---|---|---|---|
| Gender | 0.252 | ||
| Female | 14 (58) | 22 (46) | |
| Male | 10 (42) | 26 (54) | |
| Family history | 0.580 | ||
| No | 15 (63) | 25 (52) | |
| Yes | 9 (38) | 23 (48) | |
| Laterality | <0.0001 | ||
| Unilateral | 13 (54) | 5 (10) | |
| Bilateral | 11 (46) | 43 (90) | |
| International classificationa | 0.004 | ||
| A | 2 (8) | 3 (6) | |
| B | 1 (4) | 10 (21) | |
| C | 0 (0) | 8 (17) | |
| D | 12 (50) | 7 (14) | |
| E | 9 (38) | 20 (42) | |
| Eye classification | 0.220 | ||
| Groups A, B | 3 (13) | 13 (27) | |
| Group C or worse | 21 (88) | 35 (73) | |
| Eye classification | 0.016 | ||
| Groups A–C | 3 (13) | 21 (44) | |
| Group D or worse | 21 (88) | 27 (56) | |
Values are presented as n (%). Associations were tested using the χ2 test.
a
Patient's most advanced eye.